Tarek Mohamed Mostafa

Efficacy and Safety of Roflumilast in Patients with Non-Alcoholic Steatohepatitis: A Randomized Controlled Study

Tarek Mohamed Mostafa, Mokhtar Salem Mohamed, Sherief M Abdel-salam & Dalia Refaat El-Afify · Journal of Pharmaceutical Research International · 2026

Background: Non-alcoholic fatty liver disease is the most prevalent chronic liver disease globally. There is no defined therapy for non-alcoholic steatohepatitis (NASH). Aim: This study aimed at evaluating the efficacy and safety of Roflumilast in patients with non-alcoholic NASH...